Cantor Fitzgerald slashes price target on Replimune Group Inc [REPL] – find out why.

Misty Lee

Replimune Group Inc [NASDAQ: REPL] slipped around -2.25 points on Thursday, while shares priced at $3.46 at the close of the session, down -39.40%.

Compared to the average trading volume of 9.18M shares, REPL reached a trading volume of 27550155 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Replimune Group Inc [REPL]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for REPL shares is $7.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on REPL stock is a recommendation set at 2.78. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Cantor Fitzgerald have made an estimate for Replimune Group Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on July 30, 2025. The new note on the price target was released on July 23, 2025, representing the official price target for Replimune Group Inc stock. Previously, the target price had yet another raise to $2, while BMO Capital Markets analysts kept a Underperform rating on REPL stock.

The Price to Book ratio for the last quarter was 0.80, with the Price to Cash per share for the same quarter was set at 5.17.

How has REPL stock performed recently?

Replimune Group Inc [REPL] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -42.43. With this latest performance, REPL shares dropped by -34.47% in over the last four-week period, additionally sinking by -69.91% over the last 6 months – not to mention a drop of -71.43% in the past year of trading.

Replimune Group Inc (REPL) Capital Structure & Debt Analysis

According to recent financial data for Replimune Group Inc. ( REPL), the Return on Equity (ROE) stands at -73.44%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -55.79%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Replimune Group Inc’s Return on Invested Capital (ROIC) is -68.51%, showcasing its effectiveness in deploying capital for earnings.

Replimune Group Inc (REPL) Efficiency & Liquidity Metrics

Based on Replimune Group Inc’s (REPL) latest financial statements, the Debt-to-Equity Ratio is 0.23%, indicating its reliance on debt financing relative to shareholder equity.

Replimune Group Inc (REPL) Efficiency & Liquidity Metrics

From an operational efficiency perspective, Replimune Group Inc. (REPL) effectively leverages its workforce, generating an average of -$585010.44 per employee. The company’s liquidity position is robust, with a Current Ratio of 6.94% and a Quick Ratio of 6.94%, indicating strong ability to cover short-term liabilities.

Earnings analysis for Replimune Group Inc [REPL]

With the latest financial reports released by the company, Replimune Group Inc posted -0.68/share EPS, while the average EPS was predicted by analysts to be reported at -0.74/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.06. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for REPL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Replimune Group Inc go to 22.85%.

Insider trade positions for Replimune Group Inc [REPL]

There are presently around $104.94%, or 107.08%% of REPL stock, in the hands of institutional investors. The top three institutional holders of REPL stocks are: BAKER BROS. ADVISORS LP with ownership of 10.05 million shares, which is approximately 14.5193%. PRICE T ROWE ASSOCIATES INC /MD/, holding 9.24 million shares of the stock with an approximate value of $$83.13 million in REPL stocks shares; and PRICE T ROWE ASSOCIATES INC /MD/, currently with $$50.06 million in REPL stock with ownership which is approximately 8.0394%.

DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.